LIMN

Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company headquartered in La Palma, California, specializing in the development of innovative therapies for various cancer types. The firm is committed to addressing significant unmet needs within the oncology space, leveraging advanced scientific methodologies and a rich therapeutic pipeline. With its strategic focus on clinical development, Liminatus Pharma is positioned to make a meaningful impact in the rapidly evolving cancer treatment landscape, presenting a compelling investment opportunity for institutional investors in the biotechnology sector.